We evaluate your hormone levels, metabolic markers, body composition, medical history, and current symptoms before developing a treatment strategy tailored specifically to you
In the STEP 1 trial (NEJM, 2021), semaglutide 2.4mg achieved a mean weight reduction of 14.9% over 68 weeks versus 2.4% placebo establishing a benchmark that subsequent compounds including retatrutide have sought to surpass
But for women with BMI-related fertility challenges, it represents a genuinely hopeful pathway
These biomarkers elucidate underlying resistance mechanisms by identifying resistance-prone subpopulations, metabolic adaptations, and key microenvironmental cues
Standard contraceptive precautions apply
These drugs mimic the effects of a natural hormone called GLP-1, which is involved in regulating blood sugar levels and appetite